Abstract |
Herein we describe the discovery of a series of novel adenosine A(2A) receptor antagonists. A successful hit-to-lead optimization of an HTS hit led to replacement of a metabolically labile ester moiety with a heteroaromatic group. A compound from the series, ( cyclopropanecarboxylic acid [5-(5-methyl-[1,2,4]oxadiazol-3-yl)-4-phenyl-thiazol-2-yl]- amide, compound 13), was shown to be effective in reversing haloperidol-induced hypolocomotion, a model of motor dysfunction in Parkinson's Disease.
|
Authors | Anette Graven Sams, Gitte Kobberøe Mikkelsen, Mogens Larsen, Lars Torup, Lise Tøttrup Brennum, Tenna Juul Schrøder, Benny Bang-Andersen |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 20
Issue 17
Pg. 5241-4
(Sep 01 2010)
ISSN: 1464-3405 [Electronic] England |
PMID | 20659802
(Publication Type: Journal Article)
|
Copyright | Copyright 2010 Elsevier Ltd. All rights reserved. |
Chemical References |
- Amides
- Carboxylic Acids
- Purinergic P1 Receptor Antagonists
- Receptor, Adenosine A2A
|
Topics |
- Amides
(chemistry, pharmacology)
- Carboxylic Acids
(chemistry, pharmacology)
- Purinergic P1 Receptor Antagonists
(chemistry, pharmacology)
- Receptor, Adenosine A2A
(drug effects)
- Structure-Activity Relationship
|